Glucophage XR 750 mg tablete s produljenim oslobađanjem
| Name | Glucophage XR 750 mg tablete s produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-310851737 |
| Active Substance | metforminklorid |
| Composition | jedna tableta s produljenim oslobađanjem sadrži 750 mg metforminklorida što odgovara 585 mg metformina |
| Pharmaceutical Form | tableta s produljenim oslobađanjem |
| Manufacturer | Merck Sante s.a.s., Semoy, Francuska Merck Healthcare KGaA, Darmstadt, Njemačka Merck S.L., Barcelona, Španjolska |
| Marketing Authorisation Holder | Merck d.o.o., Oreškovićeva ulica 6H/1, Zagreb, Hrvatska |
| Marketing Authorisation Date | 26.02.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/23-02/100 |
| Registration Number | 381-12-01/70-24-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BA02 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
